EBMT-EHA CAR-T 2019 | CAR T-cell therapy: the patient’s perspective

Bregje Verhoeven

Bregje Verhoeven, from the European Society for Blood & Marrow Transplantation (EBMT), Amsterdam, Netherlands, gives an insight as to the patient perspective of CAR T-cell therapy. Speaking at the 1st European CAR T-Cell Meeting, held in Paris, France, Ms Verhoeven gives advice to both the patients and institutions involved. This meeting was co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).

Share this video